<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="dict8/PMC7445369/results/search/disease/results.xml">
  <result pre="12 34, karger@karger.com pmcid: 7445369 doi: 10.1159/000508991ned-0001 : Review COVID-19" exact="Infection" post="and Neurological Complications: Present Findings and Future Predictions BeghiEttorea*FeiginValerybCasoValeriacSantaluciaPaoladLogroscinoGiancarloe[],"/>
  <result pre="caused by SARS-CoV-2, an influenza virus with neurotropic potential, presents" exact="with neurological manifestations" post="in a large proportion of the affected individuals. Disorders"/>
  <result pre="neurological manifestations in a large proportion of the affected individuals." exact="Disorders" post="of the central and peripheral nervous system are all"/>
  <result pre="proportion of the affected individuals. Disorders of the central and" exact="peripheral" post="nervous system are all present, while stroke, ataxia, seizures,"/>
  <result pre="severe complications are most likely elderly with medical comorbidities, especially" exact="hypertension" post="and other vascular risk factors. However, postinfectious complications are"/>
  <result pre="most likely elderly with medical comorbidities, especially hypertension and other" exact="vascular" post="risk factors. However, postinfectious complications are also expected. Neurological"/>
  <result pre="past and include symptoms, signs, and diseases occurring during the" exact="acute" post="phase and, not rarely, during follow-up. Postinfectious neurological complications"/>
  <result pre="and can explain the insurgence of immune-mediated diseases, including the" exact="Guillain-Barré syndrome" post="and other diseases of the central and peripheral nervous"/>
  <result pre="can explain the insurgence of immune-mediated diseases, including the Guillain-Barré" exact="syndrome" post="and other diseases of the central and peripheral nervous"/>
  <result pre="the Guillain-Barré syndrome and other diseases of the central and" exact="peripheral" post="nervous system that in the past occurred as complications"/>
  <result pre="nervous system that in the past occurred as complications of" exact="viral" post="infections and occasionally with vaccines. For these reasons, the"/>
  <result pre="system that in the past occurred as complications of viral" exact="infections" post="and occasionally with vaccines. For these reasons, the present"/>
  <result pre="with several millions of inhabitants. The public health system, mainly" exact="primary" post="care, needs to be strengthened to ensure that research"/>
  <result pre="treat, and prevent future epidemics. Keywords Coronavirus Neurological disorders Outbreak" exact="Infection" post="ref-count: page-count: Introduction An unexpected infection caused by a"/>
  <result pre="Coronavirus Neurological disorders Outbreak Infection ref-count: page-count: Introduction An unexpected" exact="infection" post="caused by a coronavirus, SARS-CoV-2, is devastating the health"/>
  <result pre="the world population and, consequently, the global economy. Although the" exact="primary" post="manifestation of COVID-19 infection is pneumonia, there is increasing"/>
  <result pre="consequently, the global economy. Although the primary manifestation of COVID-19" exact="infection" post="is pneumonia, there is increasing evidence that suggests the"/>
  <result pre="that suggests the spread to key organs other than the" exact="respiratory" post="system, among them the central and peripheral nervous system."/>
  <result pre="other than the respiratory system, among them the central and" exact="peripheral" post="nervous system. A growing body of evidence shows that"/>
  <result pre="mechanisms. While the first action can be verified during the" exact="acute" post="phase of the disease, the second can be apparent"/>
  <result pre="apparent only after days, weeks, or even months following the" exact="acute" post="phase. Many viral infections can damage the structure and"/>
  <result pre="days, weeks, or even months following the acute phase. Many" exact="viral" post="infections can damage the structure and function of the"/>
  <result pre="weeks, or even months following the acute phase. Many viral" exact="infections" post="can damage the structure and function of the nervous"/>
  <result pre="structure and function of the nervous system, manifesting as encephalitis," exact="toxic encephalopathy," post="and postinfectious demyelinating disease [2]. Coronaviruses can invade the"/>
  <result pre="the nervous system, manifesting as encephalitis, toxic encephalopathy, and postinfectious" exact="demyelinating disease" post="[2]. Coronaviruses can invade the nervous tissues involving immune-functioning"/>
  <result pre="nervous system, manifesting as encephalitis, toxic encephalopathy, and postinfectious demyelinating" exact="disease" post="[2]. Coronaviruses can invade the nervous tissues involving immune-functioning"/>
  <result pre="tissues involving immune-functioning macrophages, microglia, or astrocytes [3] and cause" exact="nerve" post="damage through direct infection pathways (circulatory and neuronal), hypoxia,"/>
  <result pre="microglia, or astrocytes [3] and cause nerve damage through direct" exact="infection" post="pathways (circulatory and neuronal), hypoxia, immune injury, attack to"/>
  <result pre="long-term neurological complications. Present Findings on the Association between COVID-19" exact="Infection" post="and the Occurrence of Neurological Disorders In one of"/>
  <result pre="the Association between COVID-19 Infection and the Occurrence of Neurological" exact="Disorders" post="In one of the first reports on neurological findings"/>
  <result pre="present in 78/214 patients (36.4%) and fell into 3 categories:" exact="central nervous system" post="(dizziness, headache, impaired consciousness, acute cerebrovascular disease, ataxia, and"/>
  <result pre="into 3 categories: central nervous system (dizziness, headache, impaired consciousness," exact="acute" post="cerebrovascular disease, ataxia, and seizure), peripheral nervous system (taste"/>
  <result pre="3 categories: central nervous system (dizziness, headache, impaired consciousness, acute" exact="cerebrovascular disease," post="ataxia, and seizure), peripheral nervous system (taste impairment, smell"/>
  <result pre="(dizziness, headache, impaired consciousness, acute cerebrovascular disease, ataxia, and seizure)," exact="peripheral" post="nervous system (taste impairment, smell impairment, vision impairment, and"/>
  <result pre="ataxia, and seizure), peripheral nervous system (taste impairment, smell impairment," exact="vision impairment," post="and nerve pain), and muscular-skeletal [5]. Stroke, ataxia, seizures,"/>
  <result pre="peripheral nervous system (taste impairment, smell impairment, vision impairment, and" exact="nerve" post="pain), and muscular-skeletal [5]. Stroke, ataxia, seizures, and depressed"/>
  <result pre="a single center in Wuhan, 11/221 patients with COVID-19 developed" exact="acute" post="ischemic stroke, 1 cerebral venous sinus thrombosis, and 1"/>
  <result pre="Wuhan, 11/221 patients with COVID-19 developed acute ischemic stroke, 1" exact="cerebral" post="venous sinus thrombosis, and 1 cerebral hemorrhage. However, patients"/>
  <result pre="acute ischemic stroke, 1 cerebral venous sinus thrombosis, and 1" exact="cerebral hemorrhage." post="However, patients with these severe complications are more likely"/>
  <result pre="more likely to be elderly and present medical comorbidities, especially" exact="vascular" post="risk factors such as hypertension [6]. Hypoxic encephalopathy has"/>
  <result pre="and present medical comorbidities, especially vascular risk factors such as" exact="hypertension" post="[6]. Hypoxic encephalopathy has been diagnosed in 20% of"/>
  <result pre="comorbidities, especially vascular risk factors such as hypertension [6]. Hypoxic" exact="encephalopathy" post="has been diagnosed in 20% of 113 deceased patients"/>
  <result pre="31% incidence of thrombotic complications in ICU patients with COVID-19" exact="infection" post="has been documented in 184 ICU patients with proven"/>
  <result pre="In a meta-analysis of 6 studies in patients with COVID-19," exact="cerebrovascular disease" post="was identified as a risk factor along with hypertension,"/>
  <result pre="a meta-analysis of 6 studies in patients with COVID-19, cerebrovascular" exact="disease" post="was identified as a risk factor along with hypertension,"/>
  <result pre="was identified as a risk factor along with hypertension, diabetes," exact="chronic" post="obstructive pulmonary disease, and cardiovascular disease [9]. Other neurological"/>
  <result pre="as a risk factor along with hypertension, diabetes, chronic obstructive" exact="pulmonary" post="disease, and cardiovascular disease [9]. Other neurological features were"/>
  <result pre="factor along with hypertension, diabetes, chronic obstructive pulmonary disease, and" exact="cardiovascular disease" post="[9]. Other neurological features were observed in severe cases,"/>
  <result pre="along with hypertension, diabetes, chronic obstructive pulmonary disease, and cardiovascular" exact="disease" post="[9]. Other neurological features were observed in severe cases,"/>
  <result pre="Other neurological features were observed in severe cases, including confusion," exact="diffuse" post="corticospinal tract signs, and dysexecutive syndrome [10]. A complete"/>
  <result pre="severe cases, including confusion, diffuse corticospinal tract signs, and dysexecutive" exact="syndrome" post="[10]. A complete assessment of neurological signs is often"/>
  <result pre="confusion, diffuse corticospinal tract signs, and dysexecutive syndrome [10]. A" exact="complete" post="assessment of neurological signs is often difficult because of"/>
  <result pre="often difficult because of drug-induced neuromuscular blockade or early death." exact="Acute" post="inflammatory demyelinating polyneuropathy [11] and Miller-Fisher syndrome [12] were"/>
  <result pre="because of drug-induced neuromuscular blockade or early death. Acute inflammatory" exact="demyelinating" post="polyneuropathy [11] and Miller-Fisher syndrome [12] were also observed."/>
  <result pre="of drug-induced neuromuscular blockade or early death. Acute inflammatory demyelinating" exact="polyneuropathy" post="[11] and Miller-Fisher syndrome [12] were also observed. The"/>
  <result pre="blockade or early death. Acute inflammatory demyelinating polyneuropathy [11] and" exact="Miller-Fisher syndrome" post="[12] were also observed. The occurrence of cerebrovascular events"/>
  <result pre="or early death. Acute inflammatory demyelinating polyneuropathy [11] and Miller-Fisher" exact="syndrome" post="[12] were also observed. The occurrence of cerebrovascular events"/>
  <result pre="also observed. The occurrence of cerebrovascular events in patients with" exact="arterial hypertension" post="and cardiovascular disease might be related to a direct"/>
  <result pre="observed. The occurrence of cerebrovascular events in patients with arterial" exact="hypertension" post="and cardiovascular disease might be related to a direct"/>
  <result pre="occurrence of cerebrovascular events in patients with arterial hypertension and" exact="cardiovascular disease" post="might be related to a direct effect of the"/>
  <result pre="of cerebrovascular events in patients with arterial hypertension and cardiovascular" exact="disease" post="might be related to a direct effect of the"/>
  <result pre="disease might be related to a direct effect of the" exact="infection" post="itself or an inappropriate host response. However, in case"/>
  <result pre="Lessons from the Past Neurological complications as sequelae of influenza" exact="infection" post="have been documented for over a century. In an"/>
  <result pre="the pandemic and postulated that influenza &quot;attacked more particularly the" exact="nerve" post="centres&quot; based on the &quot;very pronounced nerve sequelae observed.&quot;"/>
  <result pre="more particularly the nerve centres&quot; based on the &quot;very pronounced" exact="nerve" post="sequelae observed.&quot; In the discussion, the authors argued that"/>
  <result pre="(meningitis), poliomyelitis, and polio-encephalitis was more than coincidence. Most importantly," exact="encephalitis" post="lethargica and postencephalitic Parkinsonism have been closely associated with"/>
  <result pre="was more than coincidence. Most importantly, encephalitis lethargica and postencephalitic" exact="Parkinsonism" post="have been closely associated with the 1918 flu pandemic."/>
  <result pre="flu pandemic. Several other viruses have been then associated with" exact="secondary" post="Parkinsonisms. These include Coksackievirus; Japanese encephalitis B, St. Louis,"/>
  <result pre="have been then associated with secondary Parkinsonisms. These include Coksackievirus;" exact="Japanese encephalitis" post="B, St. Louis, and West Nile viruses; and HIV"/>
  <result pre="been then associated with secondary Parkinsonisms. These include Coksackievirus; Japanese" exact="encephalitis" post="B, St. Louis, and West Nile viruses; and HIV"/>
  <result pre="B, St. Louis, and West Nile viruses; and HIV [15]." exact="Viral" post="Infections and Neurological Complications Coronaviruses are not the only"/>
  <result pre="St. Louis, and West Nile viruses; and HIV [15]. Viral" exact="Infections" post="and Neurological Complications Coronaviruses are not the only viruses"/>
  <result pre="to Zika virus, serious neurological complications were observed, including microcephaly," exact="Guillain-Barré syndrome" post="(GBS), and eye infections [16]. Less frequently reported neurological"/>
  <result pre="Zika virus, serious neurological complications were observed, including microcephaly, Guillain-Barré" exact="syndrome" post="(GBS), and eye infections [16]. Less frequently reported neurological"/>
  <result pre="complications were observed, including microcephaly, Guillain-Barré syndrome (GBS), and eye" exact="infections" post="[16]. Less frequently reported neurological complications include encephalitis/meningoencephalitis, acute"/>
  <result pre="eye infections [16]. Less frequently reported neurological complications include encephalitis/meningoencephalitis," exact="acute" post="disseminated encephalomyelitis, myelitis, cerebrovascular diseases (ischemic infarction and vasculopathy),"/>
  <result pre="acute disseminated encephalomyelitis, myelitis, cerebrovascular diseases (ischemic infarction and vasculopathy)," exact="seizures" post="and encephalopathy, sensory polyneuropathy, and neuronopathy [17]. H1N1 2009"/>
  <result pre="and young adults being the most susceptible age-groups [18]. In" exact="Central" post="America and the Dominican Republic, H1N1 pandemic was lethal"/>
  <result pre="spread [20]. Many neurological symptoms have been described during the" exact="acute" post="phase, including altered mental status, seizures, and meningoencephalitis, among"/>
  <result pre="concerns. These include EV-A71, which has caused epidemics of hand-foot-and-mouth" exact="disease" post="(HFMD) in Southeast Asia, and EV-D68, which recently caused"/>
  <result pre="and EV-D68, which recently caused a large outbreak of severe" exact="lower" post="respiratory tract disease in North America [23]. HFMD is"/>
  <result pre="EV-D68, which recently caused a large outbreak of severe lower" exact="respiratory" post="tract disease in North America [23]. HFMD is associated"/>
  <result pre="recently caused a large outbreak of severe lower respiratory tract" exact="disease" post="in North America [23]. HFMD is associated with acute"/>
  <result pre="tract disease in North America [23]. HFMD is associated with" exact="acute" post="neurological disease in children and a substantial burden of"/>
  <result pre="disease in North America [23]. HFMD is associated with acute" exact="neurological disease" post="in children and a substantial burden of long-term neurological"/>
  <result pre="in North America [23]. HFMD is associated with acute neurological" exact="disease" post="in children and a substantial burden of long-term neurological"/>
  <result pre="children and a substantial burden of long-term neurological sequelae [24]." exact="Infections" post="due to these viruses are associated with severe neurological"/>
  <result pre="associated with severe neurological complications, including, in addition to HFMD," exact="aseptic meningitis," post="encephalitis, acute flaccid paralysis, and acute flaccid myelitis. Other"/>
  <result pre="neurological complications, including, in addition to HFMD, aseptic meningitis, encephalitis," exact="acute" post="flaccid paralysis, and acute flaccid myelitis. Other Coronaviruses and"/>
  <result pre="addition to HFMD, aseptic meningitis, encephalitis, acute flaccid paralysis, and" exact="acute" post="flaccid myelitis. Other Coronaviruses and Neurological Disorders Severe acute"/>
  <result pre="flaccid paralysis, and acute flaccid myelitis. Other Coronaviruses and Neurological" exact="Disorders" post="Severe acute respiratory syndrome (SARS) is a zoonotic respiratory"/>
  <result pre="paralysis, and acute flaccid myelitis. Other Coronaviruses and Neurological Disorders" exact="Severe" post="acute respiratory syndrome (SARS) is a zoonotic respiratory disease"/>
  <result pre="and acute flaccid myelitis. Other Coronaviruses and Neurological Disorders Severe" exact="acute" post="respiratory syndrome (SARS) is a zoonotic respiratory disease caused"/>
  <result pre="acute flaccid myelitis. Other Coronaviruses and Neurological Disorders Severe acute" exact="respiratory" post="syndrome (SARS) is a zoonotic respiratory disease caused by"/>
  <result pre="flaccid myelitis. Other Coronaviruses and Neurological Disorders Severe acute respiratory" exact="syndrome" post="(SARS) is a zoonotic respiratory disease caused by a"/>
  <result pre="Neurological Disorders Severe acute respiratory syndrome (SARS) is a zoonotic" exact="respiratory" post="disease caused by a coronavirus (SARS-CoV) starting in Southeast"/>
  <result pre="Disorders Severe acute respiratory syndrome (SARS) is a zoonotic respiratory" exact="disease" post="caused by a coronavirus (SARS-CoV) starting in Southeast Asia"/>
  <result pre="induce several neurological diseases, including polyneuropathy, encephalitis, and aortic ischemic" exact="stroke" post="[25]. Autopsy studies demonstrated that signs of cerebral edema"/>
  <result pre="aortic ischemic stroke [25]. Autopsy studies demonstrated that signs of" exact="cerebral edema" post="and meningeal vasodilation could be detected in most cases"/>
  <result pre="in the vessel wall, ischemic changes of neurons, demyelination of" exact="nerve" post="fibers, and SARS-CoV particles and genome sequences could be"/>
  <result pre="SARS-CoV particles and genome sequences could be detected in the" exact="brain" post="[26]. Another zoonotic disease is the Middle East respiratory"/>
  <result pre="sequences could be detected in the brain [26]. Another zoonotic" exact="disease" post="is the Middle East respiratory syndrome (MERS) that in"/>
  <result pre="the brain [26]. Another zoonotic disease is the Middle East" exact="respiratory" post="syndrome (MERS) that in 2012 marked the introduction of"/>
  <result pre="brain [26]. Another zoonotic disease is the Middle East respiratory" exact="syndrome" post="(MERS) that in 2012 marked the introduction of MERS-CoV,"/>
  <result pre="neuroinvasive, with 25.7% of patients developing insanity and 8.6% experiencing" exact="seizures" post="[27]. Neurological symptoms occurring during the infection process also"/>
  <result pre="and 8.6% experiencing seizures [27]. Neurological symptoms occurring during the" exact="infection" post="process also included disturbance of consciousness, paralysis, ischemic stroke,"/>
  <result pre="of consciousness, paralysis, ischemic stroke, GBS, and other poisoning or" exact="infectious" post="neuropathies [28]. Seropositivity for coronaviruses has been reported in"/>
  <result pre="has been reported in a variety of neurological disorders, including" exact="encephalitis" post="[29], optic neuritis [30], multiple sclerosis [31], and Parkinson's"/>
  <result pre="reported in a variety of neurological disorders, including encephalitis [29]," exact="optic neuritis" post="[30], multiple sclerosis [31], and Parkinson's disease [32]. Neurological"/>
  <result pre="in a variety of neurological disorders, including encephalitis [29], optic" exact="neuritis" post="[30], multiple sclerosis [31], and Parkinson's disease [32]. Neurological"/>
  <result pre="variety of neurological disorders, including encephalitis [29], optic neuritis [30]," exact="multiple sclerosis" post="[31], and Parkinson's disease [32]. Neurological Complications: Direct Viral"/>
  <result pre="including encephalitis [29], optic neuritis [30], multiple sclerosis [31], and" exact="Parkinson's disease" post="[32]. Neurological Complications: Direct Viral Effects versus Adverse Effects"/>
  <result pre="encephalitis [29], optic neuritis [30], multiple sclerosis [31], and Parkinson's" exact="disease" post="[32]. Neurological Complications: Direct Viral Effects versus Adverse Effects"/>
  <result pre="multiple sclerosis [31], and Parkinson's disease [32]. Neurological Complications: Direct" exact="Viral" post="Effects versus Adverse Effects of Vaccines A significantly increased"/>
  <result pre="Effects of Vaccines A significantly increased incidence of GBS after" exact="swine flu" post="vaccination in the USA in 1976 led to a"/>
  <result pre="influenza vaccine antigens may induce cross-reactive anti-ganglioside antibodies, eventually causing" exact="peripheral" post="nerve damage. During the influenza pandemic in 2009, the"/>
  <result pre="vaccine antigens may induce cross-reactive anti-ganglioside antibodies, eventually causing peripheral" exact="nerve" post="damage. During the influenza pandemic in 2009, the possible"/>
  <result pre="Complications or Stochastic Findings? The increased incidence of GBS after" exact="swine flu" post="vaccination raised several claims that the vaccine was the"/>
  <result pre="claims that the vaccine was the cause of several other" exact="infectious" post="or immune-mediated diseases, including postvaccinal encephalopathy, myelopathy, and peripheral"/>
  <result pre="other infectious or immune-mediated diseases, including postvaccinal encephalopathy, myelopathy, and" exact="peripheral" post="nerve lesions [37]. These claims led the US government"/>
  <result pre="infectious or immune-mediated diseases, including postvaccinal encephalopathy, myelopathy, and peripheral" exact="nerve" post="lesions [37]. These claims led the US government to"/>
  <result pre="provide reference data on the incidence of a number of" exact="infectious" post="and immune-mediated inflammatory neurological diseases, including encephalitis and aseptic"/>
  <result pre="a number of infectious and immune-mediated inflammatory neurological diseases, including" exact="encephalitis" post="and aseptic meningitis [38], acute transverse myelitis [39], brachial"/>
  <result pre="of infectious and immune-mediated inflammatory neurological diseases, including encephalitis and" exact="aseptic meningitis" post="[38], acute transverse myelitis [39], brachial plexus neuropathy [40],"/>
  <result pre="infectious and immune-mediated inflammatory neurological diseases, including encephalitis and aseptic" exact="meningitis" post="[38], acute transverse myelitis [39], brachial plexus neuropathy [40],"/>
  <result pre="immune-mediated inflammatory neurological diseases, including encephalitis and aseptic meningitis [38]," exact="acute" post="transverse myelitis [39], brachial plexus neuropathy [40], and GBS"/>
  <result pre="neurological diseases, including encephalitis and aseptic meningitis [38], acute transverse" exact="myelitis" post="[39], brachial plexus neuropathy [40], and GBS [41], and"/>
  <result pre="including encephalitis and aseptic meningitis [38], acute transverse myelitis [39]," exact="brachial plexus neuropathy" post="[40], and GBS [41], and calculate the excess number"/>
  <result pre="and aseptic meningitis [38], acute transverse myelitis [39], brachial plexus" exact="neuropathy" post="[40], and GBS [41], and calculate the excess number"/>
  <result pre="an etiological agent (in our case, the COVID-19) and a" exact="neurological disease." post="Problems Arising When Assessing a Cause-Effect Relationship between the"/>
  <result pre="Arising When Assessing a Cause-Effect Relationship between the Virus and" exact="Acute" post="and Long-Term Complications The unexpected clinical manifestations of the"/>
  <result pre="cause-effect relationship between the extent of contagion, development of symptoms," exact="disease" post="severity and complications, and outcome. These measures included, among"/>
  <result pre="transports, amusement places, healthcare facilities, nursing homes, etc.); (2) the" exact="uncontrolled" post="use of RT-PCR-based assays on respiratory specimens, some of"/>
  <result pre="homes, etc.); (2) the uncontrolled use of RT-PCR-based assays on" exact="respiratory" post="specimens, some of them with still unproven validity and"/>
  <result pre="be contrasted with the intrinsic heterogeneity of the interaction of" exact="viral infection" post="and host reaction, which includes (1) the reproductive number;"/>
  <result pre="contrasted with the intrinsic heterogeneity of the interaction of viral" exact="infection" post="and host reaction, which includes (1) the reproductive number;"/>
  <result pre="of treatments and treatment categories. Thus, the insurgence of a" exact="neurological disease" post="in the acute phase of the infection must be"/>
  <result pre="treatments and treatment categories. Thus, the insurgence of a neurological" exact="disease" post="in the acute phase of the infection must be"/>
  <result pre="categories. Thus, the insurgence of a neurological disease in the" exact="acute" post="phase of the infection must be assessed in the"/>
  <result pre="of a neurological disease in the acute phase of the" exact="infection" post="must be assessed in the light of this complex"/>
  <result pre="of this complex scenario, in order to verify whether the" exact="disease" post="is the direct effect of the viral aggression (meningitis,"/>
  <result pre="verify whether the disease is the direct effect of the" exact="viral" post="aggression (meningitis, encephalitis, or acute encephalopathy) or an indirect,"/>
  <result pre="the direct effect of the viral aggression (meningitis, encephalitis, or" exact="acute" post="encephalopathy) or an indirect, immune-mediated, effect. Compared to the"/>
  <result pre="in the area due to the incidence of that same" exact="disease" post="in the general population. Preventive Measures and Treatments The"/>
  <result pre="and proper treatment. This might have occurred for people with" exact="stroke" post="[42, 43] and can be expected for other conditions"/>
  <result pre="contagion or who presented with general or neurological manifestations of" exact="infection" post="had perhaps a negative impact on the introduction of"/>
  <result pre="others, the measurement of D-dimer at the onset of the" exact="infection" post="to prevent thrombosis [44]. Last, the uncontrolled use of"/>
  <result pre="of D-dimer at the onset of the infection to prevent" exact="thrombosis" post="[44]. Last, the uncontrolled use of several drugs without"/>
  <result pre="onset of the infection to prevent thrombosis [44]. Last, the" exact="uncontrolled" post="use of several drugs without waiting for the results"/>
  <result pre="COVID-19 is entirely based on clinical series that, in the" exact="absence of" post="controls and a population base, give us only a"/>
  <result pre="one of these disorders considering that the incidence of the" exact="disease" post="has been calculated in several countries in all continents"/>
  <result pre="Health Metrics and Evaluation, site of the Global Burden of" exact="Disease" post="(GBD) Collaboration, has developed projections of resource utilization in"/>
  <result pre="at risk of incurring the most severe complications of the" exact="infectious disease," post="and, conversely, the infection itself might be a source"/>
  <result pre="most severe complications of the infectious disease, and, conversely, the" exact="infection" post="itself might be a source of neurological complications. These"/>
  <result pre="complications. These observations have profound reflections on the management of" exact="acute" post="neurological conditions like stroke and chronic conditions like multiple"/>
  <result pre="profound reflections on the management of acute neurological conditions like" exact="stroke" post="and chronic conditions like multiple sclerosis, neurodegenerative disorders, and"/>
  <result pre="on the management of acute neurological conditions like stroke and" exact="chronic" post="conditions like multiple sclerosis, neurodegenerative disorders, and myasthenia gravis."/>
  <result pre="of acute neurological conditions like stroke and chronic conditions like" exact="multiple sclerosis," post="neurodegenerative disorders, and myasthenia gravis. Furthermore, the implementation of"/>
  <result pre="stroke and chronic conditions like multiple sclerosis, neurodegenerative disorders, and" exact="myasthenia gravis." post="Furthermore, the implementation of social distancing and interruption of"/>
  <result pre="have induced significant problems in the clinical care of several" exact="chronic" post="neurological conditions. The likely worsening of the outcomes of"/>
  <result pre="to medical care is part of the impact of COVID-19" exact="infection" post="that should be measured [48]. Curbing the impact of"/>
  <result pre="that should be measured [48]. Curbing the impact of future" exact="viral" post="epidemics, or comparable diseases, requires increased long-term investments in"/>
  <result pre="neuroinvasive potential of SARS-CoV2 may play a role in the" exact="respiratory" post="failure of COVID-19 patientsJ Med Virol2020Feb 27 2MichalicováABhideKBhideMKováčAHow viruses"/>
  <result pre="infiltrate the central nervous systemActa Virol201761(04)39340029186956 3Al-ObaidiMMJBahadoranAWangSMManikamRRajuCSSekaranSDDisruption of the blood" exact="brain" post="barrier is vital property of neurotropic viral infection of"/>
  <result pre="of the blood brain barrier is vital property of neurotropic" exact="viral infection" post="of the central nervous systemActa Virol201862(1)162729521099 4WuYXuXChenZDuanJHashimotoKYangLet al.Nervous system"/>
  <result pre="the blood brain barrier is vital property of neurotropic viral" exact="infection" post="of the central nervous systemActa Virol201862(1)162729521099 4WuYXuXChenZDuanJHashimotoKYangLet al.Nervous system"/>
  <result pre="the central nervous systemActa Virol201862(1)162729521099 4WuYXuXChenZDuanJHashimotoKYangLet al.Nervous system involvement after" exact="infection" post="with COVID-19 and other coronavirusesBrain Behav Immun2020Mar 30S0889-1591(20)303573 5MaoLJinHWangMHuYChenSHeQet"/>
  <result pre="Immun2020Mar 30S0889-1591(20)303573 5MaoLJinHWangMHuYChenSHeQet al.Neurologic manifestations of hospitalized patients with coronavirus" exact="disease" post="2019 in Wuhan, ChinaJAMA Neurol2020Apr 10e201127 6GuanWJNiZYHuYLiangWHOuCQHeJXet al.Clinical characteristics"/>
  <result pre="in Wuhan, ChinaJAMA Neurol2020Apr 10e201127 6GuanWJNiZYHuYLiangWHOuCQHeJXet al.Clinical characteristics of coronavirus" exact="disease" post="2019 in ChinaN Engl J Med2020Apr 30382(18)17082032109013 7ChenTWuDChenHYanWYangDChenGet al.Clinical"/>
  <result pre="30382(18)17082032109013 7ChenTWuDChenHYanWYangDChenGet al.Clinical characteristics of 113 deceased patients with coronavirus" exact="disease" post="2019: retrospective studyBMJ2020Mar 26368m109132217556 8KlokFKruipMvan der MeerNArbousMGommersDKantKet al.Incidence of"/>
  <result pre="features in severe SARS-CoV-2 infectionN Engl J Med202064382(23)226870 11ToscanoGPalmeriniFRavagliaSRuizLInvernizziPCuzzoniMGet al.Guillain-Barré" exact="syndrome" post="associated with SARS-CoV-2N Engl J Med2020Apr 17 12Gutiérrez-OrtizCMéndezARodrigo-ReySSan Pedro-MurilloEBermejo-GuerreroLGordo-MañasRet"/>
  <result pre="associated with SARS-CoV-2N Engl J Med2020Apr 17 12Gutiérrez-OrtizCMéndezARodrigo-ReySSan Pedro-MurilloEBermejo-GuerreroLGordo-MañasRet al.Miller" exact="Fisher syndrome" post="and polyneuritis cranialis in COVID-19Neurology2020Apr 1710.1212/WNL.0000000000009619. doi: 10.1212/WNL. 0000000000009619."/>
  <result pre="with SARS-CoV-2N Engl J Med2020Apr 17 12Gutiérrez-OrtizCMéndezARodrigo-ReySSan Pedro-MurilloEBermejo-GuerreroLGordo-MañasRet al.Miller Fisher" exact="syndrome" post="and polyneuritis cranialis in COVID-19Neurology2020Apr 1710.1212/WNL.0000000000009619. doi: 10.1212/WNL. 0000000000009619."/>
  <result pre="COVID-19Neurology2020Apr 1710.1212/WNL.0000000000009619. doi: 10.1212/WNL. 0000000000009619. Epub ahead of print 13ZhaoHShenDZhouHLiuJChenSGuillain-Barré" exact="syndrome" post="associated with SARS-CoV-2 infection: causality or coincidence?Lancet Neurol202019(5)383432246917 14HenryJSmeyneRJJangHMillerBOkunMSParkinsonism"/>
  <result pre="clinical characteristics of deaths associated with influenza A(H1N1) pdm09 in" exact="Central" post="America and Dominican Republic 2009–2010BMC Public Health20151573426227404 20ColtartCELindseyBGhinaiIJohnsonAMHeymannDLThe Ebola"/>
  <result pre="virus diseaseCurr Infect Dis Rep201719(5)1928391498 22WongGQiuXBiYFormentyPSprecherAJacobsMet al.More challenges from Ebola:" exact="infection" post="of the central nervous systemJ Infect Dis2016214(Suppl 3)S294627707893 23BaggenJThibautHStratingJvan"/>
  <result pre="review and meta-analysisEur J Paediatr Neurol201822(5)7637329778429 25TsaiLHsiehSChangYNeurological manifestations in severe" exact="acute" post="respiratory syndromeActa Neurol Taiwan200514(3)113916252612 26GuJGongEZhangBZhengJGaoZZhongYet al.Multiple organ infection and"/>
  <result pre="and meta-analysisEur J Paediatr Neurol201822(5)7637329778429 25TsaiLHsiehSChangYNeurological manifestations in severe acute" exact="respiratory" post="syndromeActa Neurol Taiwan200514(3)113916252612 26GuJGongEZhangBZhengJGaoZZhongYet al.Multiple organ infection and the"/>
  <result pre="in severe acute respiratory syndromeActa Neurol Taiwan200514(3)113916252612 26GuJGongEZhangBZhengJGaoZZhongYet al.Multiple organ" exact="infection" post="and the pathogenesis of SARSJ Exp Med2005202(3)4152416043521 27SaadMOmraniASBaigKBahloulAElzeinFMatinMAet al.Clinical"/>
  <result pre="al.Clinical aspects and outcomes of 70 patients with Middle East" exact="respiratory" post="syndrome coronavirus infection: a single-center experience in Saudi ArabiaInt"/>
  <result pre="aspects and outcomes of 70 patients with Middle East respiratory" exact="syndrome" post="coronavirus infection: a single-center experience in Saudi ArabiaInt J"/>
  <result pre="Infect Dis201429301625303830 28KimJEHeoJHKimHOSongSHParkSSParkTHet al.Neurological complications during treatment of Middle East" exact="respiratory" post="syndromeJ Clin Neurol201713(3)2273328748673 29LiYLiHFanRWenBZhangJCaoXet al.Coronavirus infections in the central"/>
  <result pre="treatment of Middle East respiratory syndromeJ Clin Neurol201713(3)2273328748673 29LiYLiHFanRWenBZhangJCaoXet al.Coronavirus" exact="infections" post="in the central nervous system and respiratory tract show"/>
  <result pre="East respiratory syndromeJ Clin Neurol201713(3)2273328748673 29LiYLiHFanRWenBZhangJCaoXet al.Coronavirus infections in the" exact="central nervous system" post="and respiratory tract show distinct features in hospitalized childrenIntervirology201659(3)163928103598"/>
  <result pre="Neurol201713(3)2273328748673 29LiYLiHFanRWenBZhangJCaoXet al.Coronavirus infections in the central nervous system and" exact="respiratory" post="tract show distinct features in hospitalized childrenIntervirology201659(3)163928103598 30DessauRLisbyGFrederiksenJCoronaviruses in"/>
  <result pre="in hospitalized childrenIntervirology201659(3)163928103598 30DessauRLisbyGFrederiksenJCoronaviruses in spinal fluid of patients with" exact="acute" post="monosymptomatic optic neuritisActa Neurol Scand1999100(2)889110442448 31SalmiAZiolaBHoviTReunanenMAntibodies to coronaviruses OC43"/>
  <result pre="neuritisActa Neurol Scand1999100(2)889110442448 31SalmiAZiolaBHoviTReunanenMAntibodies to coronaviruses OC43 and 229E in" exact="multiple sclerosis" post="patientsNeurology198232(3)29256278362 32FazziniEFlemingJFahnSCerebrospinal fluid antibodies to coronavirus in patients with"/>
  <result pre="to coronavirus in patients with Parkinson's diseaseMov Disord19927(2)15381316552 33SchonbergerLBBregmanDJSullivan-BolyaiJZKeenlysideRAZieglerDWRetailliauHFet al.Guillain-Barre" exact="syndrome" post="following vaccination in the National Influenza Immunization Program, United"/>
  <result pre="Immunization Program, United States, 1976–1977Am J Epidemiol1979110(2)10523463869 34GaleottiFMassariMD'AlessandroRBeghiEChiòALogroscinoGet al.Risk of" exact="Guillain-Barré syndrome" post="after 2010–2011 influenza vaccinationEur J Epidemiol201328(5)4334423543123 35SejvarJJBaughmanALWiseMMorganOWPopulation incidence of"/>
  <result pre="Program, United States, 1976–1977Am J Epidemiol1979110(2)10523463869 34GaleottiFMassariMD'AlessandroRBeghiEChiòALogroscinoGet al.Risk of Guillain-Barré" exact="syndrome" post="after 2010–2011 influenza vaccinationEur J Epidemiol201328(5)4334423543123 35SejvarJJBaughmanALWiseMMorganOWPopulation incidence of"/>
  <result pre="syndrome after 2010–2011 influenza vaccinationEur J Epidemiol201328(5)4334423543123 35SejvarJJBaughmanALWiseMMorganOWPopulation incidence of" exact="Guillain-Barré" post="syndrome: a systematic review and meta-analysisNeuroepidemiology201136(2)1233321422765 36NachamkinIShadomySVMoranAPCoxNFitzgeraldCUngHet al.Anti-ganglioside antibody"/>
  <result pre="by swine (A/NJ/1976/H1N1) and other influenza vaccines: insights into vaccine-associated" exact="Guillain-Barré" post="syndromeJ Infect Dis2008198(2)2263318522505 37PoserCNeurological complications of swine influenza vaccinationActa"/>
  <result pre="insights into vaccine-associated Guillain-Barré syndromeJ Infect Dis2008198(2)2263318522505 37PoserCNeurological complications of" exact="swine influenza" post="vaccinationActa Neurol Scand198266(4)413316128862 38BeghiENicolosiAKurlandLTMulderDWHauserWAShusterLEncephalitis and aseptic meningitis, Olmsted County,"/>
  <result pre="37PoserCNeurological complications of swine influenza vaccinationActa Neurol Scand198266(4)413316128862 38BeghiENicolosiAKurlandLTMulderDWHauserWAShusterLEncephalitis and" exact="aseptic meningitis," post="Olmsted County, Minnesota, 1950–1981: I. EpidemiologyAnn Neurol198416(3)283946148911 39BeghiEKurlandLTMulderDWIncidence of"/>
  <result pre="meningitis, Olmsted County, Minnesota, 1950–1981: I. EpidemiologyAnn Neurol198416(3)283946148911 39BeghiEKurlandLTMulderDWIncidence of" exact="acute" post="transverse myelitis in rochester, Minnesota, 1970–1980, and implications with"/>
  <result pre="County, Minnesota, 1950–1981: I. EpidemiologyAnn Neurol198416(3)283946148911 39BeghiEKurlandLTMulderDWIncidence of acute transverse" exact="myelitis" post="in rochester, Minnesota, 1970–1980, and implications with respect to"/>
  <result pre="1970–1980, and implications with respect to influenza vaccineNeuroepidemiology19821(3)17688 40BeghiEKurlandLTMulderDWNicolosiABrachial plexus" exact="neuropathy" post="in the population of Rochester, Minnesota, 1970–1981Ann Neurol198518(3)32032996415 41BeghiEKurlandLTMulderDWWiederholtWCGuillain-Barré"/>
  <result pre="transmission dynamics of SARS-CoV-2 through the postpandemic periodScience2020May 22368(6493)860832291278 46SejvarJJPfeiferDSchonbergerLBGuillain-barré" exact="syndrome" post="following influenza vaccination: causal or coincidental?Curr Infect Dis Rep201113(4)3879821681501"/>
  <result pre="MEDRXIV/2020/074732 48CapozzoRZoccolellaSMusioMBaroneRAccogliMLogroscinoGTelemedicine is a useful tool to deliver care to" exact="Amyotrophic Lateral Sclerosis" post="patients during COVID-19 pandemic: results from Southern ItalyALS &amp;amp;"/>
 </snippets>
</snippetsTree>
